<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">rmt</journal-id><journal-title-group><journal-title xml:lang="ru">Общая реаниматология</journal-title><trans-title-group xml:lang="en"><trans-title>General Reanimatology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1813-9779</issn><issn pub-type="epub">2411-7110</issn><publisher><publisher-name>FSBI "SRIGR" RAMS</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15360/1813-9779-2019-4-32-41</article-id><article-id custom-type="elpub" pub-id-type="custom">rmt-1787</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЕ ИССЛЕДОВАНИЯ И ПРАКТИКА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL STUDIES AND PRACTICE</subject></subj-group></article-categories><title-group><article-title>Состояние иммунитета и его влияние на частоту развития полиорганной недостаточности у пациентов после операций на сердце</article-title><trans-title-group xml:lang="en"><trans-title>Immunity and Its Effect on the Incidence of Multiple Organ Failure in Patients after the Heart Surgery</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Партылова</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Partylova</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>62000, г. Екатеринбург, ул. Волгоградская, д. 185 </p></bio><bio xml:lang="en"><p>Elena A. Partylova</p><p>185 Volgogradskaya Str., 62000 Yekaterinburg</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Петрищев</surname><given-names>Ю. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Petrishchev</surname><given-names>Yu. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Юрий Иванович Петрищев </p><p>62000, г. Екатеринбург, ул. Волгоградская, д. 185</p></bio><bio xml:lang="en"><p>Yury I. Petrishchev</p><p>185 Volgogradskaya Str., 62000 Yekaterinburg</p></bio><email xlink:type="simple">jurpetr76@rambler.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кудрявцев</surname><given-names>И. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kudryavtsev</surname><given-names>I. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>197376, г. Санкт-Петербург, ул. Академика Павлова, д. 12 </p></bio><bio xml:lang="en"><p>Igor V. Kudryavtsev</p><p>12 Academician Pavlova Str., 197376 Saint Petersburg</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Малкова</surname><given-names>О. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Malkova</surname><given-names>O. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>62000, г. Екатеринбург, ул. Волгоградская, д. 185 </p></bio><bio xml:lang="en"><p>Olga G. Malkova</p><p>185 Volgogradskaya Str., 62000 Yekaterinburg</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Левит</surname><given-names>А. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Levit</surname><given-names>A. L.</given-names></name></name-alternatives><bio xml:lang="ru"><p>62000, г. Екатеринбург, ул. Волгоградская, д. 185 </p></bio><bio xml:lang="en"><p>Alexander L. Levit</p><p>185 Volgogradskaya Str., 62000 Yekaterinburg</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Свердловская Областная Клиническая Больница №1</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Sverdlovsk Regional Clinical Hospital №1</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Институт экспериментальной медицины, Первый Санкт-Петербургский государственный медицинский университет им. И. П. Павлова Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Experimental Medicine Institute, I. P. Pavlov First Saint-Petersburg State Medical University, Ministry of Health of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>04</day><month>09</month><year>2019</year></pub-date><volume>15</volume><issue>4</issue><fpage>32</fpage><lpage>41</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Партылова Е.А., Петрищев Ю.И., Кудрявцев И.В., Малкова О.Г., Левит А.Л., 2019</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="ru">Партылова Е.А., Петрищев Ю.И., Кудрявцев И.В., Малкова О.Г., Левит А.Л.</copyright-holder><copyright-holder xml:lang="en">Partylova E.A., Petrishchev Y.I., Kudryavtsev I.V., Malkova O.G., Levit A.L.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.reanimatology.com/rmt/article/view/1787">https://www.reanimatology.com/rmt/article/view/1787</self-uri><abstract><p>Цель исследования — выявить компоненты иммунитета, позволяющие предсказать развитие полиорганной недостаточности у пациентов после операций на сердце.</p><sec><title>Материал и методы</title><p>Материал и методы. В исследование включили 40 пациентов, оперированных в плановом порядке. Критерием включения служило наличие показаний для проведения кардиохирургического вмешательства. Критерием исключения — наличие у пациентов инфекционного эндокардита. До операции и через 24 часа исследовали общий анализ крови, с подсчетом количества лейкоцитов и лимфоцитов, фенотип иммунокомпетентных клеток с использованием моноклональных антител, а также проводили количественную оценку компонентов комплемента 3 и 4, и прокальцитонина. Всем пациентам проводили оценку полиорганной недостаточности (ПОН) с использованием шкалы SOFA.</p></sec><sec><title>Результаты</title><p>Результаты. Результаты показали, что кардиохирургическое вмешательство приводило к развитию ПОН, статистически значимым разнонаправленным изменениям как в количественном, так и в качественном составе всех клеток иммунной системы, значимому изменению концентрации С3 и С4 компонентов каскада комплемента и плазменного содержания прокальцитонина. При проведении ROC анализа выявили, что относительное содержание моноцитов менее 7,1% от количества лейкоцитов так же, как и абсолютное содержание моноцитов с фенотипом CD14+HLA-DR+ менее 0,32_109/л в дооперационном периоде, и концентрация С3 компонента комплемента менее 0,52 г/л также, как и максимальный балл SOFA в послеоперационном периоде являлись предикторами развития ПОН в послеоперационном периоде.</p></sec><sec><title>Заключение</title><p>Заключение. Компоненты врожденного иммунитета позволяют раньше, чем шкала SOFA построить прогноз исхода операций на сердце.</p></sec></abstract><trans-abstract xml:lang="en"><p>The purpose of the study is to identify the components of immunity, which might predict the development of multiple organ failure in patients after heart surgery.</p><sec><title>Material and methods</title><p>Material and methods. The study included 40 patients who were operated in cardiac surgery Department. The inclusion criteria were the presence of indications for cardiac surgery. The exclusion criteria were the presence of infective endocarditis in patients. Before the operation and after 24 hours we studied the blood level of leukocytes and lymphocytes. We analyzed the phenotype of immune cells using monoclonal antibodies, serum levels of procalcitonin and C3 and C4 complement components. All patients were evaluated for multiple organ disfunction (MOD) using the SOFA scale.</p><p>The results showed that cardiac surgery leads to the development of MOD, statistically significant multidirectional changes in both quantitative and qualitative composition of all cells of the immune system, significant changes in the level of C3 and C4 components of the cascade of complement and plasma level of pro-calcitonin. ROC analysis was revealed that the relative content of monocytes is less than 7.1% of the number of leukocytes as well as the absolute content of monocytes with the CD14 + HLA-DR + phenotype less than 0.32_109/l in the preoperative period, and the C3 level of the complement component less than 0.52 g/l, as well as the maximum SOFA score in the postoperative period, were the best predictors of MOD after the procedures.</p></sec><sec><title>Conclusion</title><p>Conclusion. The components of innate immunity make it possible to predict the complication of the cardiac surgery, earlier than the SOFA scale.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>моноциты</kwd><kwd>компоненты каскада комплемента</kwd><kwd>фенотип CD14+HLA-DR+</kwd><kwd>врожденный иммунитет</kwd><kwd>SOFA</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Monocytes</kwd><kwd>components of the complement cascade</kwd><kwd>phenotype CD14 + HLA-DR +</kwd><kwd>innate immunity</kwd><kwd>SOFA</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Понасенко А.В., Синицкий М.Ю., Хуторная М.В., Барбараш О.Л. Генетические маркеры системной воспалительной реакции в кардиохирургии (обзор). Общая реаниматология. 2017; 13 (6): 48–59. DOI: 10.15360/1813-9779-2017-6-48-59</mixed-citation><mixed-citation xml:lang="en">Ponasenko A.V., Sinitsky M.Y., Khutornaya M.V., Barabash O.L. Genetic Markers of Systemic Inflammatory Response in Cardiac Surgery (Review). Obshchaya reanimatologiya=General Reanimatology. 2017; 13 (6): 48–59. [In Russ., In Engl.] DOI: 10.15360/1813-9779-2017-6-48-59</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Mizock B.A. The Multiple Organ Dysfunction Syndrom. Disease-amonth. 55 (8): 476-526 September 2009. DOI: 10.1016/j.disamonth.2009.04.002.</mixed-citation><mixed-citation xml:lang="en">Mizock B.A. The Multiple Organ Dysfunction Syndrom. Disease-amonth. 55 (8): 476-526 September 2009. DOI: 10.1016/j.disamonth.2009.04.002.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Федерякин Д.В., Гончарук А.В., Анохин А.В., Джи’арах Мунзер Д.О. Динамика когнитивных функций и провоспалительных цитокинов при различных вариантах аорто-коронарного шунтирования. Общая реаниматология. 2018; 14 (6): 4–11. DOI: 10.15360/18139779-2018-6-4-11.</mixed-citation><mixed-citation xml:lang="en">Federyakin D.V., Goncharuk A.V., Anokhin A.V., Dj’Arah Munzer D.O. Dynamics of Cognitive Functions and Proinflammatory Cytokines in Different Variants of Coronary Artery Bypass Surgery. Obshchaya reanimatologiya= General Reanimatology. 2018; 14 (6): 4–11. [In Russ., In Engl.] DOI: 10.15360/1813-9779-2018-6-4-11.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Bone R.C. Immunologic dissonance: A continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and multiple organ dysfunction syndrome (MODS). Ann Intern Med. 1996 Oct 15; 125: 680–687.</mixed-citation><mixed-citation xml:lang="en">Bone R.C. Immunologic dissonance: A continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and multiple organ dysfunction syndrome (MODS). Ann Intern Med. 1996 Oct 15; 125: 680–687.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Munford R. S., Pugin J. Normal responses to injury prevent systemic inflammation and can be immunosuppressive. Am J Respir Crit Care Med. 2001 Feb; 163 (2): 316–321. DOI: 10.1164/ajrccm.163.2.2007102.</mixed-citation><mixed-citation xml:lang="en">Munford R. S., Pugin J. Normal responses to injury prevent systemic inflammation and can be immunosuppressive. Am J Respir Crit Care Med. 2001 Feb; 163 (2): 316–321. DOI: 10.1164/ajrccm.163.2.2007102.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Venet F., Lepape A., Monneret G. Clinical review: flow cytometry perspectives in the ICU – from diagnosis of infection to monitoring of injury-induced immune dysfunctions. Crit. Care. 2011; 15 (5): 231. DOI: 10.1186/cc10333.</mixed-citation><mixed-citation xml:lang="en">Venet F., Lepape A., Monneret G. Clinical review: flow cytometry perspectives in the ICU – from diagnosis of infection to monitoring of injury-induced immune dysfunctions. Crit. Care. 2011; 15 (5): 231. DOI: 10.1186/cc10333.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Monneret G., Venet F., Pachot A., Lepape A. Monitoring immune dysfunctions in the septic patient: A new skin for the old ceremony. Mol. Med. 2008. Jan-Feb; 14 (1–2): 64–78. DOI: 10.2119/2007-00102.Monneret.</mixed-citation><mixed-citation xml:lang="en">Monneret G., Venet F., Pachot A., Lepape A. Monitoring immune dysfunctions in the septic patient: A new skin for the old ceremony. Mol. Med. 2008. Jan-Feb; 14 (1–2): 64–78. DOI: 10.2119/2007-00102.Monneret.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Hoesel L.M., Neff T.A., Neff S.B., Younger J.G., Olle E.W., Gao H., Pianko M.J., Bernacki K.D., Sarma J.V., Ward P.A. Harmful and protective roles of neutrophils in sepsis. Shock. 2005 Jul; 24 (1): 40–47.</mixed-citation><mixed-citation xml:lang="en">Hoesel L.M., Neff T.A., Neff S.B., Younger J.G., Olle E.W., Gao H., Pianko M.J., Bernacki K.D., Sarma J.V., Ward P.A. Harmful and protective roles of neutrophils in sepsis. Shock. 2005 Jul; 24 (1): 40–47.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Adib-Conquy M., Cavaillon J.M. Compensatory anti-inflammatory response syndrome. Thromb Haemost. 2009 Jan; 101 (1): 36–47.</mixed-citation><mixed-citation xml:lang="en">Adib-Conquy M., Cavaillon J.M. Compensatory anti-inflammatory response syndrome. Thromb Haemost. 2009 Jan; 101 (1): 36-47.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Monneret G., Lepape A., Voirin N., Bohe J., Venet F., Debard A.L., Thizy H., Bienvenu J., Gueyffier F., Vanhems P. Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock. Intensive Care Med. 2006 Aug; 32 (8): 1175–1183. DOI: 10.1007/s00134-006-0204-8.</mixed-citation><mixed-citation xml:lang="en">Monneret G., Lepape A., Voirin N., Bohe J., Venet F., Debard A.L., Thizy H., Bienvenu J., Gueyffier F., Vanhems P. Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock. Intensive Care Med. 2006 Aug; 32 (8): 1175–1183. DOI: 10.1007/s00134-006-0204-8.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Nierhaus A., Montag B., Timmler N., Frings D.P., Gutensohn K., Jung R., Schneider C.G., Pothmann W., Brassel A.K., Schulte A., Esch J. Reversal of immunoparalysis by recombinant human granulocyte-macrophage colony-stimulating factor in patients with severe sepsis. Intensive Care Med. 2003 Apr; 29 (4): 646–651. DOI: 10.1007/s00134-003-1666-6.</mixed-citation><mixed-citation xml:lang="en">Nierhaus A., Montag B., Timmler N., Frings D.P., Gutensohn K., Jung R., Schneider C.G., Pothmann W., Brassel A.K., Schulte A., Esch J. Reversal of immunoparalysis by recombinant human granulocyte-macrophage colony-stimulating factor in patients with severe sepsis. Intensive Care Med. 2003 Apr; 29 (4): 646–651. DOI: 10.1007/s00134-003-1666-6.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Danikas D.D., Karakantza M., Theodorou G.L., Sakellaropoulos G.C., Gogos C.A. Prognostic value of phagocytic activity of neutrophils and monocytes in sepsis. Correlation to CD64 and CD14 antigen expression. Clin Exp Immunol. 2008 Oct; 154 (1): 87–97. DOI: 10.1111/j.13652249.2008.03737.x.</mixed-citation><mixed-citation xml:lang="en">Danikas D.D., Karakantza M., Theodorou G.L., Sakellaropoulos G.C., Gogos C.A. Prognostic value of phagocytic activity of neutrophils and monocytes in sepsis. Correlation to CD64 and CD14 antigen expression. Clin Exp Immunol. 2008 Oct; 154 (1): 87–97. DOI: 10.1111/j.13652249.2008.03737.x.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Franke A., Lante W., Zoeller L.G., Kurig E., Weinhold C., Markewitz A. Delayed recovery of human leukocyte antigen-DR expression after cardiac surgery with early non-lethal postoperative complications: only an epiphenomenon? Interact Cardiovasc Thorac Surg. 2008 Apr; 7 (2): 207–211. DOI: 10.1510/icvts.2007.158899.</mixed-citation><mixed-citation xml:lang="en">Franke A., Lante W., Zoeller L.G., Kurig E., Weinhold C., Markewitz A. Delayed recovery of human leukocyte antigen-DR expression after cardiac surgery with early non-lethal postoperative complications: only an epiphenomenon? Interact Cardiovasc Thorac Surg. 2008 Apr; 7 (2): 207–211. DOI: 10.1510/icvts.2007.158899.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Kim O. Y., Monsel A., Bertrand M., Coriat P., Cavaillon J. M., Adib-Conquy M. Differential down-regulation of HLA-DR on monocyte subpopulations during systemic inflammation. Crit Care. 2010; 14 (2): R61. DOI: 10.1186/cc8959.</mixed-citation><mixed-citation xml:lang="en">Kim O. Y., Monsel A., Bertrand M., Coriat P., Cavaillon J. M., Adib-Conquy M. Differential down-regulation of HLA-DR on monocyte subpopulations during systemic inflammation. Crit Care. 2010; 14 (2): R61. DOI: 10.1186/cc8959.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Головкин А.С., Матвеева В.Г., Кудрявцев И.В., Григорьев Е.В., Великанова Е.А., Байракова Ю.В. Субпопуляции моноцитов крови при неосложненном течении периоперационного периода коронарного шунтирования. Медицинская иммунология. 2012; 14 (4–5): 305–312. DOI: 10.15789/1563-0625-2012-4-5-305-312.</mixed-citation><mixed-citation xml:lang="en">Golovkin A.S., Matveeva V.G., Kudryavcev I.V., Grigorev E.V., Velikanova E.A., Bajrakova Yu.V. Subpopulations of blood monocytes with uncomplicated during the perioperative period of coronary artery bypass grafting. Medicinskaya immunologiya. 2012; 14 (4–5): 305–312. [In Russ.] DOI: 10.15789/1563-0625-2012-4-5-305-312.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Ceriani R., Mazzoni M., Bortone F., Gandini S., Solinas C., Susini G, Parodi O. Application of the Sequential Organ Failure Assessment Score to Cardiac Surgical Patients. Chest. 2003 Apr; 123 (4): 1229–1239.</mixed-citation><mixed-citation xml:lang="en">Ceriani R., Mazzoni M., Bortone F., Gandini S., Solinas C., Susini G, Parodi O. Application of the Sequential Organ Failure Assessment Score to Cardiac Surgical Patients. Chest. 2003 Apr; 123 (4): 1229–1239.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Doerr F., Badreldin A. M., Heldwein M.B., Bossert T., Richter M., Lehmann T., Bayer O., Hekmat K. A comparative study of four intensive care outcome prediction models in cardiac surgery patients. J Cardiothorac Surg. 2011 Mar 1; 6: 21. DOI: 10.1186/1749-8090-6-21.</mixed-citation><mixed-citation xml:lang="en">Doerr F., Badreldin A. M., Heldwein M.B., Bossert T., Richter M., Lehmann T., Bayer O., Hekmat K. A comparative study of four intensive care outcome prediction models in cardiac surgery patients. J Cardiothorac Surg. 2011 Mar 1; 6: 21. DOI: 10.1186/1749-8090-6-21.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Wan S., LeClerc J.L., Vincent J.L. Inflammatory response to cardiopulmonary bypass. Mechanisms involved and possible therapeutic strategies. Chest 1997; 112: 679–692.</mixed-citation><mixed-citation xml:lang="en">Wan S., LeClerc J.L., Vincent J.L. Inflammatory response to cardiopulmonary bypass. Mechanisms involved and possible therapeutic strategies. Chest 1997; 112: 679–692.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Paparella D., Yau T.M., Young E. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardiothorac Surg. 2002 Feb; 21 (2): 232–44.</mixed-citation><mixed-citation xml:lang="en">Paparella D., Yau T.M., Young E. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardiothorac Surg. 2002 Feb; 21 (2): 232–244.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Laffey J. G., Boylan J. F., Cheng D. C. The systemic inflammatory response to cardiac surgery. Implications for the anesthesiologist. Anesthesiology 2002; 97: 215–252.</mixed-citation><mixed-citation xml:lang="en">Laffey J. G., Boylan J. F., Cheng D. C. The systemic inflammatory response to cardiac surgery. Implications for the anesthesiologist. Anesthesiology 2002; 97: 215–252.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Понасенко А.В., Синицкий М.Ю., Хуторная М.В., Барбараш О.Л. Генетические макеры системной воспалительной реакции в кардиохирургии (обзор). Общая реаниматология. 2017; 13 (6): 48–59. DOI: 10.15360/1813-9779-2017-6-48-59.</mixed-citation><mixed-citation xml:lang="en">Ponasenko A.V., Sinitsky M.Y., Khutornaya M.V., Barabash O.L. Genetic Markers of Systemic Inflammatory Response in Cardiac Surgery (Review). Obshchaya reanimatologiya=General Reanimatology. 2017; 13 (6): 48–59. [In Russ., In Engl.]. DOI: 10.15360/1813-9779-2017-6-48-59.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Pfortmueller C. A., Meisel C., Fux M., Schefold J. C. Assessment of immune organ dysfunction in critical illness: utility of innate immune response markers. Intensive Care Med Exp. 2017 Dec; 5: 49. DOI: 10.1186/s40635-017-0163-0.</mixed-citation><mixed-citation xml:lang="en">Pfortmueller C. A., Meisel C., Fux M., Schefold J. C. Assessment of immune organ dysfunction in critical illness: utility of innate immune response markers. Intensive Care Med Exp. 2017 Dec; 5: 49. DOI: 10.1186/s40635-017-0163-0.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Rittirsch D., Redland H., Huber-Lang M. Role of Complement in Multiorgan Failure. Clin Dev Immunol. 2012; 2012: 962927. DOI: 10.1155/2012/962927.</mixed-citation><mixed-citation xml:lang="en">Rittirsch D., Redland H., Huber-Lang M. Role of Complement in Multiorgan Failure. Clin Dev Immunol. 2012; 2012: 962–927. DOI: 10.1155/2012/962927.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Menges P., Kessler W., Kloecker C., Feuerherd M., Gaubert S., Diedrich S., van der Linde J., A. Hegenbart, Busemann A., Traeger T., Cziupka K., Heidecke C.-D., Maier S. Surgical Trauma and Postoperative Immune Dysfunction. Eur Surg Res 2012; 48: 180–186. DOI: 10.1159/000338196.</mixed-citation><mixed-citation xml:lang="en">Menges P., Kessler W., Kloecker C., Feuerherd M., Gaubert S., Diedrich S., van der Linde J., A. Hegenbart, Busemann A., Traeger T., Cziupka K., Heidecke C.-D., Maier S. Surgical Trauma and Postoperative Immune Dysfunction. Eur Surg Res 2012; 48: 180–186. DOI: 10.1159/000338196.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Grigoryev E.V., Shukevich D.L., Matveeva V.G., Kornekyuk R.A. Immunosuppression as a component of multiple organ dysfunction syndrome followed cardiac surgery. Комплексные проблемы сердечно-сосудистых заболеваний. 2018; 7 (4): 84–91. DOI: 10.17802/2306-1278-20187-4-84-91.</mixed-citation><mixed-citation xml:lang="en">Grigoryev E.V., Shukevich D.L., Matveeva V.G., Kornekyuk R.A. Immunosuppression as a component of multiple organ dysfunction syndrome followed cardiac surgery. Kompleksnye problemy serdechno-sosudistyh zabolevanij.2018; 7 (4): 84–91. DOI: 10.17802/2306-1278-2018-7-4-84-91.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Delano M.J., Ward P.A. Sepsis-induced immune dysfunction: can immune therapies reduce mortality? Clin Invest. 2016; 126 (1): 23–31. DOI: 10.1172/JCI82224.</mixed-citation><mixed-citation xml:lang="en">Delano M.J., Ward P.A. Sepsis-induced immune dysfunction: can immune therapies reduce mortality? Clin Invest. 2016; 126 (1): 23–31. DOI: 10.1172/JCI82224.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Rankin J.S., Oguntolu O., Binford R.S., Trochtenberg D.S., Muhlbaier L.H., Stratton C.W. Management of immune dysfunction after adult cardiac surgery. J Thorac Cardiovasc Surg. 2011 Sep; 142 (3): 575–580. DOI: 10.1016/j.jtcvs.2011.04.042.</mixed-citation><mixed-citation xml:lang="en">Rankin J.S., Oguntolu O., Binford R.S., Trochtenberg D.S., Muhlbaier L.H., Stratton C.W. Management of immune dysfunction after adult cardiac surgery. J Thorac Cardiovasc Surg. 2011 Sep; 142 (3): 575–580. DOI: 10.1016/j.jtcvs.2011.04.042.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Gaudriot B., Uhel F., Gregoire M., Gacouin A., Biedermann S., Roisne A., Flecher E., Le Y.Tulzo, Tarte K., Tadie J.-M. Immune Dysfunction After Cardiac Surgery with Cardiopulmonary Bypass: Beneficial Effects of Maintaining Mechanical Ventilation. Shock. 2015 Sep; 44 (3): 228–233. DOI: 10.1097/SHK.0000000000000416.</mixed-citation><mixed-citation xml:lang="en">Gaudriot B., Uhel F., Gregoire M., Gacouin A., Biedermann S., Roisne A., Flecher E., Le Y.Tulzo, Tarte K., Tadie J.-M. Immune Dysfunction After Cardiac Surgery with Cardiopulmonary Bypass: Beneficial Effects of Maintaining Mechanical Ventilation. Shock. 2015 Sep; 44 (3): 228–233. DOI: 10.1097/SHK.0000000000000416.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Bronicli R.A., Hall M. Cardiopulmonary bypass-induced inflammatory response: Pathophysiology and treatment. Pediatric Critical Care Medicine. 2016 Aug; 17 (8 Suppl 1): S272–S278. DOI: 10.1097/PCC.0000000000000759.</mixed-citation><mixed-citation xml:lang="en">Bronicli R.A., Hall M. Cardiopulmonary bypass-induced inflammatory response: Pathophysiology and treatment. Pediatric Critical Care Medicine. 2016 Aug; 17 (8 Suppl 1): S272–S278. DOI: 10.1097/PCC.0000000000000759.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
